Product launch strategy for European biopharmaceutical company

  • Identified geographical concentration of demand

  • Designed optimal distribution channel configuration

  • Developed effective marketing, promotional and communication strategies

  • A top European biopharmaceutical company with a well-diversified portfolio wanted to build an optimal product launch strategy in a number of Asian countries
  • Key challenges were:
    • Developing a roadmap to plan the launch in these Asian countries
    • Scarcity of data availability in these countries
    • Building strategies based on responses from multiple stakeholders
    • Interviewing distribution channel partners to build strategy
  • Competitive analysis:
    • Conducted detailed studies on competitors’ products within the same product category
    • Benchmarked the client vs competitors in terms of product features, pricing, reach and brand value
  • Surveys and interviews:
    • Conducted detailed customer surveys to identify unmet customer needs and devised relevant strategies for the client to address these needs
    • Interviewed channel partners
  • Strategy designing:
    • Identified key marketing strategies launched by competitors and assessed their impact on the target audience to propose best-in-class strategies
  • Built a staggered launch strategy based on geographical concentration of demand
  • Advised on optimal distribution channel configuration
  • Developed effective marketing, promotional and communication strategies for medical practitioners, wholesalers and retailers
Thank you for sharing your details

Your file will start downloading automatically

If it does not download within 1 minute,

Share this on

What we have done

Competitor benchmarking and performance gap analysis for a leading European medical device player
What we are proud of

Identified opportunities for expansion and plausible revenue streams

Identified potential geographies and activation levers from competitors

Opportunity assessment and market attractiveness for one of the top 10 pharmaceutical major
What we are proud of

Benchmarked therapeutic areas with high clinical and market potential

Developed potential market scenarios based on client needs

Assessing viability of entering the NSCLC market
What we are proud of

Evaluated unmet needs to identify potential entry points

Conducted a deep-dive study of key assets and key players

Supplier assessment and industry benchmarking for a global top 10 pharmaceutical company
What we are proud of

Optimised vendor-associated costs across geographies

Identified billing arrangements across law firms

Assessment of GCC pharmaceutical market for a global European pharma major
What we are proud of

Analysed potential for entry into the GCC pharmaceutical market

Assessed possible market drivers and barriers to entry

Research on a multiple sclerosis drug with help from global neurologists
What we are proud of

Assessed the target market size, key competitors and current pricing range

Enabled the client to take informed decisions thereby increasing market penetration

Patient treatment pathway analysis for venom allergies
What we are proud of

Increased customer/patient satisfaction and conversion rate

Gained a better understanding of stakeholders’ and patients’ behaviour along the pathway